Your session is about to expire
← Back to Search
TSUNAMI Trial Summary
This trial is testing a new drug to see if it helps people with dry eye disease by improving tear film quality and stability.
- Dry Eye Syndrome
TSUNAMI Trial Eligibility Criteria
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
TSUNAMI Trial Timeline
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
TSUNAMI Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How large is the cohort of individuals being examined in this clinical trial?
"Affirmative. The information hosted on clinicaltrials.gov highlights that this medical trial, which was initially posted on August 29th 2022, is actively seeking participants. Sixty patients have to be brought in from one site for the study to proceed as planned."
Has the FDA sanctioned Varenicline solution for use?
"Varenicline solution has been approved, so it scored a 3 on our team's safety scale."
Does this experiment presently require volunteers?
"Affirmative. According to clinicaltrials.gov, this medical research is presently recruiting volunteers who initially saw the study posted on August 29th of 2022 and was subsequently updated on the 23rd of that same month. A total of 60 people are being sought out from a single location for participation."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends